The other point to keep in mind with directors buying is they can only buy when they aren’t in possession of potentially price sensitive inside information. With an active company like VTM the directors will always have some interim information on hand (initial met test data, partial drill assays, ongoing discussions with tenement applications) which makes it difficult, if not possible, to buy any shares.
I would expect directors to enter on a CR when the company can release a cleansing statement, so they probably haven’t had a window to enter since the last CR. Can’t fault them just yet if they don’t have enough skin in the game IMO.
VTM Price at posting:
20.0¢ Sentiment: Hold Disclosure: Held
